Lee Biosolutions Comittment and Success

Maryland Heights, MO, August 21, 2015 (Newswire.com) - Lee Biosolutions Inc. is a global biotech company producing highly purified enzymes and proteins that are used in research and commercial clinical diagnostic applications. The combination of increased capabilities with  our new 41,000 square foot state-of-the-art Maryland Heights research and manufacturing facility and the scientific team’s extensive expertise with protein purification has led to increased growth opportunities for the company in areas of endocrine, inflammation, coagulation, oncology, cardiovascular and autoimmune disease markets.

Burton Lee, CEO explained, “ By strategically increasing our investment in research and manufacturing capabilities and expanding partnerships with our clients, we have carved out a successful business in the world-wide scientific community. We have developed some of the most successful purification processes in the industry and have been key suppliers to all major diagnostic companies, government and research institutions, medical research centers world-wide  .  "

" Investment in our youth today will give us a return for a lifetime"

Burton Lee, CEO

Lee Biosolutions stands out in the industry because of its historical manufacturing experience in both human and animal tissues and serum protein extraction, purification and isolation. The company can tailor the purification , development, process chromatography and protein characterization to ensure our clients  obtain the right product for their final application.

About Lee Biosolutions, Inc.

We are headquartered in a 41,000 square feet state of the art cGMP-compliant facility in Maryland Heights, MO. Lee Biosolutions is a certified, licensed ISO, FDA, EPA and USDA leader in process development and bulk manufacturing of high quality purified   enzymes and related proteins for research and clinical diagnostic tests. Lee Biosolutions products are used for such pathologies as cardiac disease, cancer, diabetes, urine analysis, coagulation, obesity, inflammatory, neurological, autoimmune diseases and immunological disorders.

Contact Information:

Burton Lee, Chief Executive Officer